ClinicalTrials.Veeva

Menu

Does Perineural Dexamethasone Prolong Duration of a Nerve Block?

Rigshospitalet logo

Rigshospitalet

Status and phase

Completed
Phase 2

Conditions

Healthy Volunteers

Treatments

Drug: Ropivacaine + placebo
Drug: Ropivacaine + dexamethasone

Study type

Interventional

Funder types

Other

Identifiers

NCT02351804
2014-004879-23 (EudraCT Number)
SM2-PJ-14

Details and patient eligibility

About

The purpose of this study is to investigate whether dexamethasone as an adjuvant to ropivacaine for adductor canal block increases duration of the sensory block, when controlling for a systemic effect using a paired design and bilateral blocks.

The investigators hypothesize that adding dexamethasone to ropivacaine will prolong block duration compared with ropivacaine + placebo.

Enrollment

20 patients

Sex

Male

Ages

18 to 30 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • American Society of Anesthesiologists class 1
  • Body Mass Index 18-30

Exclusion criteria

  • Allergy to study medication
  • Earlier trauma or surgery to lower limb
  • Diabetes Mellitus
  • Alcohol or drug abuse
  • Daily intake of opioids or steroids last 4 weeks
  • Daily intake of any analgesics last 48 hours

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Quadruple Blind

20 participants in 2 patient groups, including a placebo group

Ropivacaine + dexamethasone
Experimental group
Description:
20 ml ropivacaine 0.5% + 0.5 ml dexamethasone 4 mg7ml
Treatment:
Drug: Ropivacaine + dexamethasone
Ropivacaine + placebo
Placebo Comparator group
Description:
20 ml ropivacaine 0.5% + 0.5 ml isotonic saline ad
Treatment:
Drug: Ropivacaine + placebo

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems